Varicella Zoster, IgM antibody

The Varicella Zoster, IgM test is used to diagnose recent or acute infection with the varicella-zoster virus (VZV), which causes chickenpox and shingles during initial infection and shingles (herpes zoster) during reactivation later in life. This test detects the presence of IgM antibodies, which are typically among the first antibodies produced by the immune system in response to a new infection. A positive result for IgM antibodies generally indicates that the infection is recent or in its acute phase.

The Varicella Zoster, IgM antibody is advised if you exhibit symptoms such as fever, fatigue, headache, itchy blister like rash on the skin etc suggestive of recent VZV infections or have been exposed to the virus. It is primarily used to diagnose primary varicella (chickenpox) or to differentiate between primary infection and reactivation of the virus (shingles). This test is also important for healthcare workers, pregnant women, individuals traveling to areas where chickenpox is common, those with weak immune systems who are at higher risk for complications from VZV infections. 

No special preparation is required for this test.  However, it’s important to inform your doctor about any recent illnesses, vaccinations, or medications, as these factors may impact the results.

Lab test results may vary across laboratories. Do not self-medicate at home solely based on these test results and always consult your doctor for proper understanding of the test results. The insights from this test plays an important role in tailoring the treatment plan. In the case of suspected recent VZV infection, appropriate treatments like antiviral medications to be initiated promptly. For pregnant women and immunocompromised individuals, knowing the immunity status can guide additional preventive measures and monitoring to reduce the risk of severe complications.